184 related articles for article (PubMed ID: 33420117)
1. Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers.
Cambier L; Stachelek K; Triska M; Jubran R; Huang M; Li W; Zhang J; Li J; Cobrinik D
Sci Rep; 2021 Jan; 11(1):94. PubMed ID: 33420117
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach.
Bao Q; Gong L; Wang J; Wen J; Shen Y; Zhang W
Ann Surg Oncol; 2018 Sep; 25(9):2642-2651. PubMed ID: 29981024
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential extracellular vesicle protein markers altered in osteosarcoma from public databases.
Zhang J; Li H
Proteomics Clin Appl; 2023 Jul; 17(4):e2200084. PubMed ID: 36571514
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma.
Gao X; Gao B; Li S
Front Immunol; 2022; 13():1002742. PubMed ID: 36211364
[TBL] [Abstract][Full Text] [Related]
5. LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles.
Sinha S; Mannerström B; Seppänen-Kaijansinkko R; Kaur S
J Vis Exp; 2020 Feb; (156):. PubMed ID: 32065171
[TBL] [Abstract][Full Text] [Related]
6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
7. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.
Mannerström B; Kornilov R; Abu-Shahba AG; Chowdhury IM; Sinha S; Seppänen-Kaijansinkko R; Kaur S
Epigenetics; 2019 Apr; 14(4):352-364. PubMed ID: 30907225
[TBL] [Abstract][Full Text] [Related]
9. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma.
Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T
J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
[No Abstract] [Full Text] [Related]
11. Isolation of extracellular vesicle with different precipitation-based methods exerts a tremendous impact on the biomarker analysis for clinical plasma samples.
Peng C; Wang J; Bao Q; Wang J; Liu Z; Wen J; Zhang W; Shen Y
Cancer Biomark; 2020; 29(3):373-385. PubMed ID: 32716349
[TBL] [Abstract][Full Text] [Related]
12. Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases.
Huber J; Longaker MT; Quarto N
Front Endocrinol (Lausanne); 2023; 14():1168898. PubMed ID: 37293498
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
Liu Y; Luo G; He D
Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle.
Luu AK; Cadieux M; Wong M; Macdonald R; Jones R; Choi D; Oblak M; Brisson B; Sauer S; Chafitz J; Warshawsky D; Wood GA; Viloria-Petit AM
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328679
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
16. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
17. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
Perut F; Graziani G; Roncuzzi L; Zini N; Avnet S; Baldini N
Cells; 2022 Feb; 11(5):. PubMed ID: 35269400
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
19. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
